State Of Alaska, Department Of Revenue Bluebird Bio, Inc. Transaction History

State Of Alaska, Department Of Revenue

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 02, 2019	SELL	$59.47 - $93.1 $368,654 - $577,126	-6,199 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$75.84 - $105.21 $1,896 - $2,630	25 Added 0.4%	6,199 $787,000
Q1 2019 Apr 09, 2019	SELL	$64.44 - $104.11 $13,596 - $21,967	-211 Reduced 3.3%	6,174 $970,000
Q4 2018 Jan 10, 2019	BUY	$59.1 - $93.26 $3,841 - $6,061	65 Added 1.03%	6,385 $633,000
Q3 2018 Oct 09, 2018	BUY	$88.86 - $117.49 $47,095 - $62,269	530 Added 9.15%	6,320 $922,000
Q2 2018 Jul 10, 2018	BUY	$99.64 - $127.59 $576,915 - $738,746	5,790 New	5,790 $908,000

146

63.3M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $637M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.